Cargando…
Capacity planning in a decentralized autologous cell therapy manufacturing network for low-cost resilience
The goals for increased patient access and fast fulfillment have motivated considerable interest in autologous cell therapy manufacturing networks having multiple and geographically distributed manufacturing facilities. However, the cost of safety manufacturing capacity to mitigate supplier disrupti...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638377/ https://www.ncbi.nlm.nih.gov/pubmed/36373023 http://dx.doi.org/10.1007/s10696-022-09475-6 |